Venture capital investment in global healthtech companies is projected to reach $42 billion by the end of the year, according to Silicon Valley Bank’s latest report, “The Future of HealthTech.”
The first three quarters of 2021 closed with what SVB called an astounding $34 billion invested globally across 1,040 deals, Healthcare Finance reports.
U.S.-based virtual and hybrid care companies raised north of $9.6 billion in 2021, and the report projected $3 billion in funding for U.S. mental health companies this year. The majority of funding (60%) came from 98 mega rounds, led by the largest mega-round in healthtech history: Devoted Health’s $1.2 billion Series D funding. Read more.
